Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity
- PMID: 19403473
- DOI: 10.1542/peds.2008-2217
Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity
Abstract
Objectives: The goals were to determine the prevalence of community-acquired methicillin-resistant Staphylococcus aureus colonization in patients with atopic dermatitis and to determine whether suppression of S aureus growth with sodium hypochlorite (bleach) baths and intranasal mupirocin treatment improves eczema severity.
Methods: A randomized, investigator-blinded, placebo-controlled study was conducted with 31 patients, 6 months to 17 years of age, with moderate to severe atopic dermatitis and clinical signs of secondary bacterial infections. All patients received orally administered cephalexin for 14 days and were assigned randomly to receive intranasal mupirocin ointment treatment and sodium hypochlorite (bleach) baths (treatment arm) or intranasal petrolatum ointment treatment and plain water baths (placebo arm) for 3 months. The primary outcome measure was the Eczema Area and Severity Index score.
Results: The prevalence of community-acquired methicillin-resistant S aureus in our study (7.4% of our S aureus-positive skin cultures and 4% of our S aureus-positive nasal cultures) was much lower than that in the general population with cultures at Children's Memorial Hospital (75%-85%). Patients in the group that received both the dilute bleach baths and intranasal mupirocin treatment showed significantly greater mean reductions from baseline in Eczema Area and Severity Index scores, compared with the placebo group, at the 1-month and 3-month visits. The mean Eczema Area and Severity Index scores for the head and neck did not decrease for patients in the treatment group, whereas scores for other body sites (submerged in the dilute bleach baths) decreased at 1 and 3 months, in comparison with placebo-treated patients.
Conclusions: Chronic use of dilute bleach baths with intermittent intranasal application of mupirocin ointment decreased the clinical severity of atopic dermatitis in patients with clinical signs of secondary bacterial infections. Patients with atopic dermatitis do not seem to have increased susceptibility to infection or colonization with resistant strains of S aureus.
Comment in
-
Bleach baths to reduce severity of atopic dermatitis colonized by Staphylococcus.Arch Dermatol. 2010 May;146(5):541-3. doi: 10.1001/archdermatol.2010.58. Arch Dermatol. 2010. PMID: 20479303 No abstract available.
Similar articles
-
Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.Br J Dermatol. 2006 Oct;155(4):680-7. doi: 10.1111/j.1365-2133.2006.07410.x. Br J Dermatol. 2006. PMID: 16965415 Clinical Trial.
-
Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis.Pediatr Dermatol. 2008 Sep-Oct;25(5):528-34. doi: 10.1111/j.1525-1470.2008.00768.x. Pediatr Dermatol. 2008. PMID: 18950393
-
Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience.Pediatr Dermatol. 2011 Jan-Feb;28(1):6-11. doi: 10.1111/j.1525-1470.2010.01293.x. Epub 2010 Nov 11. Pediatr Dermatol. 2011. PMID: 21070347
-
Use of bleach baths for the treatment of infected atopic eczema.Australas J Dermatol. 2013 Nov;54(4):251-8. doi: 10.1111/ajd.12015. Epub 2013 Jan 18. Australas J Dermatol. 2013. PMID: 23330843 Review.
-
Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.Clin Infect Dis. 2003 Oct 1;37(7):933-8. doi: 10.1086/377735. Epub 2003 Sep 8. Clin Infect Dis. 2003. PMID: 13130405 Review.
Cited by
-
Treatment of Atopic Dermatitis in Children.Cureus. 2024 Sep 14;16(9):e69416. doi: 10.7759/cureus.69416. eCollection 2024 Sep. Cureus. 2024. PMID: 39403661 Free PMC article. Review.
-
Exploring the association between skin microbiota and inflammatory skin diseases: a two-sample Mendelian randomization analysis.Arch Dermatol Res. 2024 Oct 14;316(10):677. doi: 10.1007/s00403-024-03433-y. Arch Dermatol Res. 2024. PMID: 39400597
-
Global Antimicrobial Susceptibility Patterns of Staphylococcus aureus in Atopic Dermatitis: A Systematic Review and Meta-Analysis.JAMA Dermatol. 2024 Sep 25:e243360. doi: 10.1001/jamadermatol.2024.3360. Online ahead of print. JAMA Dermatol. 2024. PMID: 39320869
-
Microbiota-Derived Extracellular Vesicle as Emerging Actors in Host Interactions.Int J Mol Sci. 2024 Aug 9;25(16):8722. doi: 10.3390/ijms25168722. Int J Mol Sci. 2024. PMID: 39201409 Free PMC article. Review.
-
Eosinophil extracellular vesicles and DNA traps in allergic inflammation.Front Allergy. 2024 Aug 1;5:1448007. doi: 10.3389/falgy.2024.1448007. eCollection 2024. Front Allergy. 2024. PMID: 39148911 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
